Locations:
Search IconSearch

Novel Single-Port Robotic Urology Surgery Surpasses 1,000 Cases

Applications, outcomes and untapped potential

Surgeons in the operating room with the single-port robot

Following Food and Drug Administration (FDA) approval in 2018, a novel purpose-built single-port (SP) robotic platform has been increasingly utilized for various procedures, both in urology and across other surgical specialties.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

As the first institution to perform an SP procedure in the United States, Cleveland Clinic’s Glickman Urological Institute has been instrumental in pioneering innovative, regionalized surgical approaches, recently accomplishing an important milestone of surpassing 1,000 SP urological cases.

Jihad Kaouk, MD, Director of the Center of Advanced Robotic and Image-Guided Surgery at Cleveland Clinic’s Glickman Urological Institute, emphasizes that “single-port is not about one incision, and it is not about replacing the multi-port, rather it is about regionalizing our surgical field to the pathology area and minimize discomfort for our patients.”

What makes it unique

The SP robotic platform is unique given the narrow profile of the single robotic arm, which can simultaneously accommodate three double-jointed robotic instruments and a flexible high-definition camera. All these instruments can be introduced through a single 3 cm incision, as facilitated by a purpose-built surgical access port.

Compared to the conventional multi-port robotic platform, the SP platform offers improved maneuverability and ergonomics, especially when performing procedures in smaller and shallow surgical working spaces.

Working in a small surgical area facilitated the subsequent introductions of the transperineal and transvesical prostatectomy as well as the novel low anterior access (LAA) incision for various extraperitoneal kidney procedures.

Overall, the SP robot has facilitated multi-quadrant transperitoneal, extraperitoneal, retroperitoneal, transvesical, and transperineal access for a range of surgeries, including extraperitoneal kidney transplantation and autotransplantation, nephrectomy, pyeloplasty, prostatectomy, cystectomy as well as urinary tract reconstruction.

Advertisement

SP urologic surgery: A history of firsts at Cleveland Clinic

Cleveland Clinic was instrumental in the developmental phase of the SP robot system. After obtaining Institutional Review Board (IRB) approval in 2011, Dr. Kaouk and his team performed the first-in-human SP procedures in collaboration with Professor Villers in Lille, France. This included SP nephrectomy, SP partial nephrectomy and SP radical prostatectomy.

Then, after receiving the first clinical SP robotic system in the United States in September 2018, Cleveland Clinic’s team described the floating docking technique that significantly enabled SP procedures in shallow areas and performed several first-in-human SP procedures, including:

The team also has helped expand clinical indications for certain procedures, such as performing radical prostatectomy in patients with a hostile abdomen and with patients awake under epidural anesthesia without mechanical ventilation.

intraoperative view of single-port transvesical radical prostatectomy
Figure: Intraoperative image of SP transvesical radical prostatectomy with the robot introduced through a small 3 cm suprapubic incision, with the base of the prostate and bladder neck in view. This approach completely avoids the intraperitoneal area and bowel handling during the surgery.

Minimizing surgical morbidity and enhancing patient comfort

The opportunity to regionalize our surgical approach using the purpose-built SP platform has translated to substantive benefits towards enhancing patient comfort and minimizing perioperative morbidity.

Advertisement

Our team has demonstrated the utility of various novel, regionalized SP approaches, such as with the transvesical prostatectomy and low anterior access (LAA) retroperitoneal upper and lower tract procedures, in achieving same-day discharges in up to 92% with minimal postoperative pain, thus eliminating the need for opioid prescriptions in up to 98% of our cases.

Furthermore, the ability to complete all surgical steps of transvesical radical prostatectomy entirely from within the confines of the bladder provided the opportunity to preserve the surrounding anatomy, including the external urinary sphincter and the supporting structures of the bladder.

These translated to the additional benefits of earlier return of urinary continence, with 40% achieving immediate continence following urinary catheter removal. The preservation of the peritoneum also confers additional benefits in reducing the risk of bowel complications, such as postoperative ileus, as well as minimizing the risk of postoperative incisional hernia, hence allowing patients an earlier return to their normal activities as soon as two weeks following their respective surgery.

In addition to the advantages of the SP in promoting regionalized surgical approaches, the unique features of the purpose-built platform also allow for added flexibility and maneuverability for multi-quadrant access from a single anatomical pivot point. This distinctive ability paved the way for the implementation of novel techniques, with a notable example including SP kidney autotransplantation, which involves the completion of two separate procedures (nephrectomy and transplantation) from a single transumbilical incision site. The procedure has since been utilized for various indications, including for the management of Nutcracker syndrome.

Advertisement

Bar graphs depicting outcomes data for transvesical SP-RARP
Figure: Summarized outcome from the Single Port Advanced Research Consortium (SPARC) demonstrating the perioperative benefits of transvesical single-port (SP) robotic radical prostatectomy compared to transperitoneal and extraperitoneal approaches, especially in promoting shorter hospital length stay, reduced opioid prescription, as well as reduced Foley catheter duration.

Consortium enables larger studies with widespread benefits

With new SP procedures continuing to be described and with many new centers across the country joining the SP program, there is a growing need to conduct various clinical studies and develop evidence-based guidelines on a large multi-institutional level.

“Any new innovations need to demonstrate value for our patients and our healthcare system,” says Dr. Kaouk, who established the Single-Port Advanced Research Consortium (SPARC) in 2018.

The collaborative group has since grown to include data-sharing agreements with 27 institutions and with an additional three more in progress, continuing its mission to drive important multi-institutional studies as reflected by the various peer-reviewed publications and presentations in national and international medical congresses.

Untapped potential

While the novel purpose-built SP platform represents a significant advancement that opened a new frontier within the domains of minimally invasive surgery in urology, it is important to always remember the driver behind these innovations.

“It is important to remember that the robot is just a tool, and you have to pick the approach that best fits you, your experience, your patient, and the specific pathology,” says Dr. Kaouk.When beginning to offer SP robotic surgery, centers often face a steep learning curve. A robotic surgeon needs to perform appropriate SP training and proctoring.

References

  1. Kaouk JH, Haber GP, Autorino R, Crouzet S, Ouzzane A, Flamand V, Villers A. A novel robotic system for single-port urologic surgery: first clinical investigation. Eur Urol. 2014 Dec;66(6):1033-43. doi: 10.1016/j.eururo.2014.06.039. Epub 2014 Jul 17. PMID: 25041850.
  2. Kaouk J, Bertolo R, Eltemamy M, Garisto J. Single-Port Robot-Assisted Radical Prostatectomy: First Clinical Experience Using The SP Surgical System. Urology. 2019 Feb;124:309. doi: 10.1016/j.urology.2018.10.025. Epub 2018 Oct 24. PMID: 30367924.
  3. Lenfant L, Kim S, Aminsharifi A, Sawczyn G, Kaouk J. Floating docking technique: a simple modification to improve the working space of the instruments during single-port robotic surgery. World J Urol. 2021 Apr;39(4):1299-1305. doi: 10.1007/s00345-020-03307-8. Epub 2020 Jun 29. PMID: 32601981.
  4. Ramos R, Ferguson E, Abou Zeinab M, Soputro N, Chavali JS, Pedraza AM, Schwen Z, Mikesell C, Kaouk J. Single-port Transvesical Robot-Assisted Simple Prostatectomy: Surgical Technique and Clinical Outcomes. Eur Urol. 2024 May;85(5):445-456. doi: 10.1016/j.eururo.2023.11.012. Epub 2023 Dec 5. PMID: 38057210.
  5. Kaouk J, Beksac AT, Abou Zeinab M, Duncan A, Schwen ZR, Eltemamy M. Single Port Transvesical Robotic Radical Prostatectomy: Initial Clinical Experience and Description of Technique. Urology. 2021 Sep;155:130-137. doi: 10.1016/j.urology.2021.05.022. Epub 2021 May 24. PMID: 34038749.
  6. Chavali JS, Frainey B, Ramos R, Ferguson E, Geskin A, Soputro N, Rhee A, Kaouk J. Single-port robotic extraperitoneal pediatric pyeloplasty using low anterior access: Description of technique and initial experience. J Pediatr Urol. 2024 Jan 11:S1477-5131(24)00011-1. doi: 10.1016/j.jpurol.2024.01.009. Epub ahead of print. PMID: 38290931.
  7. Eltemamy M, Garisto J, Miller E, Wee A, Kaouk J. Single Port Robotic Extra-peritoneal Dual Kidney Transplantation: Initial Preclinical Experience and Description of the Technique. Urology. 2019 Dec;134:232-236. doi: 10.1016/j.urology.2019.09.007. Epub 2019 Sep 20. PMID: 31542461.
  8. Ferguson EL, Ramos-Carpinteyro R, Soputro N, Chavali JS, Geskin A, Kaouk JH. Single-Port Robotic Radical Prostatectomy Using Transvesical and Transperineal Access in Patients with a Hostile Abdomen. J Endourol. 2024 Feb;38(2):150-158. doi: 10.1089/end.2023.0128. Epub 2024 Jan 5. PMID: 38069569.
  9. Kaouk J, Ferguson E, Ramos-Carpinteyro R, Chavali J, Geskin A, Cummings KC, Perilla M. Transvesical Percutaneous Access Allows for Epidural Anesthesia Without Mechanical Ventilation in Single-Port Robotic Radical and Simple Prostatectomy. Urology. 2023 May;175:209-215. doi: 10.1016/j.urology.2023.01.046. Epub 2023 Feb 22. PMID: 36822243.
  10. Soputro NA, Ferguson EL, Ramos-Carpinteyro R, Chavali JS, Kaouk J. The Transition Toward Opioid-sparing Outpatient Radical Prostatectomy: A Single Institution Experience With Three Contemporary Robotic Approaches. Urology. 2023 Oct;180:140-150. doi: 10.1016/j.urology.2023.07.001. Epub 2023 Jul 16. PMID: 37454769.
  11. Ramos-Carpinteyro R, Ferguson E, Soputro N, Chavali JS, Abou Zeinab M, Pedraza A, Mikesell C, Kaouk J. Predictors of Early Continence After Single-port Transvesical Robot-assisted Radical Prostatectomy. Urology. 2024 Feb;184:176-181. doi: 10.1016/j.urology.2023.11.010. Epub 2023 Dec 2. PMID: 38048917.
  12. Soputro NA, Chavali JS, Ferguson EL, Ramos-Carpinteyro R, Calvo RS, Nguyen J, Moschovas MC, Wilder S, Okhawere K, De La Rosa RS, Saini I, Peabody J, Badani KK, Rogers C, Joseph J, Nix J, Patel V, Stifelman M, Ahmed M, Crivellaro S, Kim M, Kaouk JH. Complications of single-port robot-assisted radical prostatectomy: multi-institutional analysis from the Single-Port Advanced Research Consortium (SPARC). BJU Int. 2023 Nov 16. doi: 10.1111/bju.16228. Epub ahead of print. PMID: 37971182.
  13. Soputro NA, Ferguson EL, Ramos-Carpinteyro R, Sauer Calvo R, Nguyen J, Moschovas MC, Wilder S, Chavali JS, Okhawere KE, De La Rosa RS, Saini I, Peabody J, Badani KK, Rogers C, Joseph J, Patel V, Stifelman M, Ahmed M, Crivellaro S, Kim M, Nix J, Kaouk J. Low Risk of Postoperative Hernia Following Single-port Robot-assisted Radical Prostatectomy: A Report From the Single-port Advanced Research Consortium (SPARC). Urology. 2023 Oct;180:151-159. doi: 10.1016/j.urology.2023.07.002. Epub 2023 Jul 16. PMID: 37454768.
  14. Kaouk J, Eltemamy M, Aminsharifi A, Schwen Z, Wilson C, Abou Zeinab M, Garisto J, Lenfant L, Wee A. Initial Experience with Single-port Robotic-assisted Kidney Transplantation and Autotransplantation. Eur Urol. 2021 Sep;80(3):366-373. doi: 10.1016/j.eururo.2021.03.002. Epub 2021 Mar 31. PMID: 33810922.
  15. Abou Zeinab M, Beksac AT, Ferguson E, Kaviani A, Moschovas MC, Joseph J, Kim M, Crivellaro S, Nix J, Patel V, Kaouk J. Single-port Extraperitoneal and Transperitoneal Radical Prostatectomy: A Multi-Institutional Propensity-Score Matched Study. Urology. 2023 Jan;171:140-145. doi: 10.1016/j.urology.2022.10.001. Epub 2022 Oct 13. PMID: 36244472.

Advertisement

Related Articles

Drawing of surgeon's fingers pressing into a patient's body
Low Anterior Access Enhances Outcomes in Single-Port Robotic Urologic Surgeries

Pioneering and refining the approach in pyeloplasty, nephrectomy and more

Single-port robot docked in the operating room
November 12, 2024/Urology & Nephrology/Urology
Single-Port Pyeloplasty in a Pediatric Patient: A Novel Surgical Technique

Revolutionizing pediatric urology with a new, less invasive approach

Physician smiles at patient in a preoperative setting
September 12, 2024/Urology & Nephrology/Urology
Improving the Bladder Cancer Survivorship Experience for Women

What updated techniques, counseling and a changing workforce could mean

Photo of Dr. Bajic
Counseling Your Patients on SGLT-2 Inhibitors and Adverse Urologic Outcomes

Retrospective study shows SGLT-2 inhibitors may lead to worse urologic outcomes

Illustration of red blood cells in motion
Review Underscores Impact of Red Blood Cell Disorders on Male Reproduction

Early, individualized diagnosis and comprehensive management key to preserving fertility

UTI bacteria and artificial intelligence
AI Algorithms Accurately Predict Antibiotic Resistance in UTI

Up to 3 days faster than waiting for urine culture results

Enlarged prostate
Benign Prostatic Hyperplasia: Alternatives to Transurethral Resection

Review the advantages and disadvantages of newer interventions

Man examining prescription bottle in kitchen
February 27, 2024/Urology & Nephrology/Urology
Oral Medication Offers New Option for Testosterone Replacement

Unlike earlier pills, new drugs do not cause liver toxicity

Ad